New study shows cannabis effects on driving skills

Monday, 18 March, 2013


New research appearing online in Clinical Chemistry, the journal of American Association for Clinical Chemistry (AACC), shows that cannabis can be detected in the blood of daily smokers for a month after last intake. The scientific data in this paper by Bergamaschi et al can provide real help in the public safety need for a drugged driving policy that reduces the number of drugged driving accidents on the road.

Cannabis is second only to alcohol for causing impaired driving and motor vehicle accidents. In 2009, 12.8% of young adults reported driving under the influence of illicit drugs and in the 2007 National Roadside Survey, more drivers tested positive for drugs than for alcohol. These cannabis smokers had a tenfold increase in car crash injury compared with infrequent or non-users after adjustment for blood alcohol concentration.

In this paper, 30 male chronic daily cannabis smokers resided in a secure research unit for up to 33 days, with daily blood collection. Twenty-seven of 30 participants were THC-positive on admission, with a median (range) concentration of 1.4 µg/L (0.3-6.3). THC decreased gradually with only 1 of 11 participants negative at 26 days; 2 of 5 remained THC-positive (0.3 µg/L) for 30 days.

These results demonstrate, for the first time, that cannabinoids can be detected in blood of chronic daily cannabis smokers during a month of sustained abstinence. This is consistent with the time course of persisting neurocognitive impairment reported in recent studies and suggests that establishment of ‘per se’ THC legislation might achieve a reduction in motor vehicle injuries and deaths. This same type of per se alcohol legislation improved prosecution of drunk drivers and dramatically reduced alcohol-related deaths.

“These data have never been obtained previously due to the cost and difficulty of studying chronic daily cannabis smoking over an extended period,” said Dr Marylin Huestis of the National Institutes of Health and author on the paper. “These data add critical information to the debate about the toxicity of chronic daily cannabis smoking.”

Related Articles

Workplace drug and alcohol programs: some key considerations

When it comes to substance abuse in the workplace, construction is considered one of the...

5 biggest pitfalls of workplace D&A policies and how to avoid them

This article outlines the five biggest pitfalls of workplace drug and alcohol policies together...

Risk factor: drug and alcohol testing during COVID-19

Are drug and alcohol (D&A) testing protocols still necessary during COVID-19, or do the...


  • All content Copyright © 2023 Westwick-Farrow Pty Ltd